Industry: Medical Devices & Consumables
Published Date: 2024-04-17
Pages: 157 Pages
Report ld: 2694448
Request Sample
Customized Report
Disposable Hemoperfusion Market Size(US$)

CAGR 2024-2030
13%
Market Size,2030
USD 2,460.9
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
The global Disposable Hemoperfusion market size was US$ 1035.9 million in 2023 and is forecast to a readjusted size of US$ 2460.9 million by 2030 with a CAGR of 13.0% during the forecast period 2024-2030.
China is the largest market with about 48% market share. Followed by Europe and Japan, accounting for about 35% market share.
The key players are Baxter International, Asahi Kasei Corporation, CytoSorbentsCompany 11, Kaneka Pharma, Toray Medical, Aier, Tianjin Zibo High Technology, Biosun Corporation, Kangbei Medical Device, Jafron Biomedical etc. Top 3 companies occupied about 64% revenue market share.
In terms of sales (consumption) side, this report focuses on the sales of Disposable Hemoperfusion by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Disposable Hemoperfusion market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Disposable Hemoperfusion market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Disposable Hemoperfusion in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Disposable Hemoperfusion manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Disposable Hemoperfusion sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Disposable Hemoperfusion Definition
1.2 Market by Type
1.2.1 Global Disposable Hemoperfusion Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Charcoal Hemoperfusion
1.2.3 Certain Resins Hemoperfusion
1.3 Market Segment by Application
1.3.1 Global Disposable Hemoperfusion Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Overdose
1.3.3 Specific Intoxications
1.3.4 Certain Autoimmune Diseases
1.3.5 Hepatic Encephalopathy
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Disposable Hemoperfusion Sales
2.1 Global Disposable Hemoperfusion Revenue Estimates and Forecasts 2019-2030
2.2 Global Disposable Hemoperfusion Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Disposable Hemoperfusion Revenue by Region
2.3.1 Global Disposable Hemoperfusion Revenue by Region (2019-2024)
2.3.2 Global Disposable Hemoperfusion Revenue by Region (2025-2030)
2.4 Global Disposable Hemoperfusion Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Disposable Hemoperfusion Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Disposable Hemoperfusion Sales Quantity by Region
2.6.1 Global Disposable Hemoperfusion Sales Quantity by Region (2019-2024)
2.6.2 Global Disposable Hemoperfusion Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Disposable Hemoperfusion Sales Quantity by Manufacturers
3.1.1 Global Disposable Hemoperfusion Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Disposable Hemoperfusion Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Disposable Hemoperfusion Sales in 2023
3.2 Global Disposable Hemoperfusion Revenue by Manufacturers
3.2.1 Global Disposable Hemoperfusion Revenue by Manufacturers (2019-2024)
3.2.2 Global Disposable Hemoperfusion Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Disposable Hemoperfusion Revenue in 2023
3.3 Global Disposable Hemoperfusion Sales Price by Manufacturers
3.4 Global Key Players of Disposable Hemoperfusion, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Disposable Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Disposable Hemoperfusion, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Disposable Hemoperfusion, Product Offered and Application
3.8 Global Key Manufacturers of Disposable Hemoperfusion, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Disposable Hemoperfusion Sales Quantity by Type
4.1.1 Global Disposable Hemoperfusion Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Disposable Hemoperfusion Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Disposable Hemoperfusion Sales Quantity Market Share by Type (2019-2030)
4.2 Global Disposable Hemoperfusion Revenue by Type
4.2.1 Global Disposable Hemoperfusion Historical Revenue by Type (2019-2024)
4.2.2 Global Disposable Hemoperfusion Forecasted Revenue by Type (2025-2030)
4.2.3 Global Disposable Hemoperfusion Revenue Market Share by Type (2019-2030)
4.3 Global Disposable Hemoperfusion Price by Type
4.3.1 Global Disposable Hemoperfusion Price by Type (2019-2024)
4.3.2 Global Disposable Hemoperfusion Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Disposable Hemoperfusion Sales Quantity by Application
5.1.1 Global Disposable Hemoperfusion Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Disposable Hemoperfusion Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Disposable Hemoperfusion Sales Quantity Market Share by Application (2019-2030)
5.2 Global Disposable Hemoperfusion Revenue by Application
5.2.1 Global Disposable Hemoperfusion Historical Revenue by Application (2019-2024)
5.2.2 Global Disposable Hemoperfusion Forecasted Revenue by Application (2025-2030)
5.2.3 Global Disposable Hemoperfusion Revenue Market Share by Application (2019-2030)
5.3 Global Disposable Hemoperfusion Price by Application
5.3.1 Global Disposable Hemoperfusion Price by Application (2019-2024)
5.3.2 Global Disposable Hemoperfusion Price Forecast by Application (2025-2030)
6 North America
6.1 North America Disposable Hemoperfusion Sales by Company
6.1.1 North America Disposable Hemoperfusion Revenue by Company (2019-2024)
6.1.2 North America Disposable Hemoperfusion Sales Quantity by Company (2019-2024)
6.2 North America Disposable Hemoperfusion Market Size by Type
6.2.1 North America Disposable Hemoperfusion Sales Quantity by Type (2019-2030)
6.2.2 North America Disposable Hemoperfusion Revenue by Type (2019-2030)
6.3 North America Disposable Hemoperfusion Market Size by Application
6.3.1 North America Disposable Hemoperfusion Sales Quantity by Application (2019-2030)
6.3.2 North America Disposable Hemoperfusion Revenue by Application (2019-2030)
6.4 North America Disposable Hemoperfusion Market Size by Country
6.4.1 North America Disposable Hemoperfusion Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Disposable Hemoperfusion Revenue by Country (2019-2030)
6.4.3 North America Disposable Hemoperfusion Sales Quantity by Country (2019-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Disposable Hemoperfusion Sales by Company
7.1.1 Europe Disposable Hemoperfusion Sales Quantity by Company (2019-2024)
7.1.2 Europe Disposable Hemoperfusion Revenue by Company (2019-2024)
7.2 Europe Disposable Hemoperfusion Market Size by Type
7.2.1 Europe Disposable Hemoperfusion Sales Quantity by Type (2019-2030)
7.2.2 Europe Disposable Hemoperfusion Revenue by Type (2019-2030)
7.3 Europe Disposable Hemoperfusion Market Size by Application
7.3.1 Europe Disposable Hemoperfusion Sales Quantity by Application (2019-2030)
7.3.2 Europe Disposable Hemoperfusion Revenue by Application (2019-2030)
7.4 Europe Disposable Hemoperfusion Market Size by Country
7.4.1 Europe Disposable Hemoperfusion Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Disposable Hemoperfusion Revenue by Country (2019-2030)
7.4.3 Europe Disposable Hemoperfusion Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Disposable Hemoperfusion Sales by Company
8.1.1 China Disposable Hemoperfusion Sales Quantity by Company (2019-2024)
8.1.2 China Disposable Hemoperfusion Revenue by Company (2019-2024)
8.2 China Disposable Hemoperfusion Market Size by Type
8.2.1 China Disposable Hemoperfusion Sales Quantity by Type (2019-2030)
8.2.2 China Disposable Hemoperfusion Revenue by Type (2019-2030)
8.3 China Disposable Hemoperfusion Market Size by Application
8.3.1 China Disposable Hemoperfusion Sales Quantity by Application (2019-2030)
8.3.2 China Disposable Hemoperfusion Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Disposable Hemoperfusion Sales by Company
9.1.1 APAC Disposable Hemoperfusion Sales Quantity by Company (2019-2024)
9.1.2 APAC Disposable Hemoperfusion Revenue by Company (2019-2024)
9.2 APAC Disposable Hemoperfusion Market Size by Type
9.2.1 APAC Disposable Hemoperfusion Sales Quantity by Type (2019-2030)
9.2.2 APAC Disposable Hemoperfusion Revenue by Type (2019-2030)
9.3 APAC Disposable Hemoperfusion Market Size by Application
9.3.1 APAC Disposable Hemoperfusion Sales Quantity by Application (2019-2030)
9.3.2 APAC Disposable Hemoperfusion Revenue by Application (2019-2030)
9.4 APAC Disposable Hemoperfusion Market Size by Region
9.4.1 APAC Disposable Hemoperfusion Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Disposable Hemoperfusion Revenue by Region (2019-2030)
9.4.3 APAC Disposable Hemoperfusion Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Disposable Hemoperfusion Sales by Company
10.1.1 Middle East, Africa and Latin America Disposable Hemoperfusion Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Disposable Hemoperfusion Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Disposable Hemoperfusion Market Size by Type
10.2.1 Middle East, Africa and Latin America Disposable Hemoperfusion Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Disposable Hemoperfusion Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Disposable Hemoperfusion Market Size by Application
10.3.1 Middle East, Africa and Latin America Disposable Hemoperfusion Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Disposable Hemoperfusion Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Disposable Hemoperfusion Market Size by Country
10.4.1 Middle East, Africa and Latin America Disposable Hemoperfusion Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Disposable Hemoperfusion Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Disposable Hemoperfusion Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Baxter International
11.1.1 Baxter International Company Information
11.1.2 Baxter International Overview
11.1.3 Baxter International Disposable Hemoperfusion Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Baxter International Disposable Hemoperfusion Products and Services
11.1.5 Baxter International Disposable Hemoperfusion SWOT Analysis
11.1.6 Baxter International Recent Developments
11.2 Asahi Kasei Corporation
11.2.1 Asahi Kasei Corporation Company Information
11.2.2 Asahi Kasei Corporation Overview
11.2.3 Asahi Kasei Corporation Disposable Hemoperfusion Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 Asahi Kasei Corporation Disposable Hemoperfusion Products and Services
11.2.5 Asahi Kasei Corporation Disposable Hemoperfusion SWOT Analysis
11.2.6 Asahi Kasei Corporation Recent Developments
11.3 CytoSorbentsCompany 11
11.3.1 CytoSorbentsCompany 11 Company Information
11.3.2 CytoSorbentsCompany 11 Overview
11.3.3 CytoSorbentsCompany 11 Disposable Hemoperfusion Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 CytoSorbentsCompany 11 Disposable Hemoperfusion Products and Services
11.3.5 CytoSorbentsCompany 11 Disposable Hemoperfusion SWOT Analysis
11.3.6 CytoSorbentsCompany 11 Recent Developments
11.4 Kaneka Pharma
11.4.1 Kaneka Pharma Company Information
11.4.2 Kaneka Pharma Overview
11.4.3 Kaneka Pharma Disposable Hemoperfusion Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 Kaneka Pharma Disposable Hemoperfusion Products and Services
11.4.5 Kaneka Pharma Disposable Hemoperfusion SWOT Analysis
11.4.6 Kaneka Pharma Recent Developments
11.5 Toray Medical
11.5.1 Toray Medical Company Information
11.5.2 Toray Medical Overview
11.5.3 Toray Medical Disposable Hemoperfusion Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Toray Medical Disposable Hemoperfusion Products and Services
11.5.5 Toray Medical Disposable Hemoperfusion SWOT Analysis
11.5.6 Toray Medical Recent Developments
11.6 Aier
11.6.1 Aier Company Information
11.6.2 Aier Overview
11.6.3 Aier Disposable Hemoperfusion Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Aier Disposable Hemoperfusion Products and Services
11.6.5 Aier Disposable Hemoperfusion SWOT Analysis
11.6.6 Aier Recent Developments
11.7 Tianjin Zibo High Technology
11.7.1 Tianjin Zibo High Technology Company Information
11.7.2 Tianjin Zibo High Technology Overview
11.7.3 Tianjin Zibo High Technology Disposable Hemoperfusion Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.7.4 Tianjin Zibo High Technology Disposable Hemoperfusion Products and Services
11.7.5 Tianjin Zibo High Technology Disposable Hemoperfusion SWOT Analysis
11.7.6 Tianjin Zibo High Technology Recent Developments
11.8 Biosun Corporation
11.8.1 Biosun Corporation Company Information
11.8.2 Biosun Corporation Overview
11.8.3 Biosun Corporation Disposable Hemoperfusion Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.8.4 Biosun Corporation Disposable Hemoperfusion Products and Services
11.8.5 Biosun Corporation Disposable Hemoperfusion SWOT Analysis
11.8.6 Biosun Corporation Recent Developments
11.9 Kangbei Medical Device
11.9.1 Kangbei Medical Device Company Information
11.9.2 Kangbei Medical Device Overview
11.9.3 Kangbei Medical Device Disposable Hemoperfusion Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.9.4 Kangbei Medical Device Disposable Hemoperfusion Products and Services
11.9.5 Kangbei Medical Device Disposable Hemoperfusion SWOT Analysis
11.9.6 Kangbei Medical Device Recent Developments
11.10 Jafron Biomedical
11.10.1 Jafron Biomedical Company Information
11.10.2 Jafron Biomedical Overview
11.10.3 Jafron Biomedical Disposable Hemoperfusion Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.10.4 Jafron Biomedical Disposable Hemoperfusion Products and Services
11.10.5 Jafron Biomedical Disposable Hemoperfusion SWOT Analysis
11.10.6 Jafron Biomedical Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Disposable Hemoperfusion Value Chain Analysis
12.2 Disposable Hemoperfusion Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Disposable Hemoperfusion Production Mode & Process
12.4 Disposable Hemoperfusion Sales and Marketing
12.4.1 Disposable Hemoperfusion Sales Channels
12.4.2 Disposable Hemoperfusion Distributors
12.5 Disposable Hemoperfusion Customers
13 Market Dynamics
13.1 Disposable Hemoperfusion Industry Trends
13.2 Disposable Hemoperfusion Market Drivers
13.3 Disposable Hemoperfusion Market Challenges
13.4 Disposable Hemoperfusion Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Disposable Hemoperfusion market size was US$ 1475 million in 2025 and is forecast to reach a readjusted size of US$ 3430 million by 2032 with a CAGR of 13.0% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
The global Disposable Hemoperfusion market was valued at US$ 1475 million in 2025 and is anticipated to reach US$ 3430 million by 2032, at a CAGR of 13.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
The global market for Disposable Hemoperfusion was estimated to be worth US$ 1475 million in 2025 and is projected to reach US$ 3430 million, growing at a CAGR of 13.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 93
USD 3950.00
(Single User License)
The global Disposable Hemoperfusion market is projected to grow from US$ 1320 million in 2024 to US$ 3070 million by 2031, at a CAGR of 13.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 144
USD 4900.00
(Single User License)
In 2024, the global market size of Disposable Hemoperfusion was estimated to be worth US$ 1320 million and is forecast to reach approximately US$ 3070 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 128
USD 5900.00
(Single User License)
The global Disposable Hemoperfusion market size was US$ 1320 million in 2024 and is forecast to a readjusted size of US$ 3070 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 79
USD 4250.00
(Single User License)
The global market for Disposable Hemoperfusion was estimated to be worth US$ 1320 million in 2024 and is forecast to a readjusted size of US$ 3070 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 108
USD 3950.00
(Single User License)
The global market for Disposable Hemoperfusion was valued at US$ 1320 million in the year 2024 and is projected to reach a revised size of US$ 3070 million by 2031, growing at a CAGR of 13.0% during the forecast period.
Published Date: 2025-01-16
Pages: 79
USD 2900.00
(Single User License)
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
Published Date: 2024-04-16
Pages: 152
USD 5900.00
(Single User License)
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
Published Date: 2024-04-07
Pages: 105
USD 4900.00
(Single User License)
The global Disposable Hemoperfusion market size was US$ 1475 million in 2025 and is forecast to reach a readjusted size of US$ 3430 million by 2032 with a CAGR of 13.0% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
The global Disposable Hemoperfusion market was valued at US$ 1475 million in 2025 and is anticipated to reach US$ 3430 million by 2032, at a CAGR of 13.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
The global market for Disposable Hemoperfusion was estimated to be worth US$ 1475 million in 2025 and is projected to reach US$ 3430 million, growing at a CAGR of 13.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 93
The global Disposable Hemoperfusion market is projected to grow from US$ 1320 million in 2024 to US$ 3070 million by 2031, at a CAGR of 13.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 144
In 2024, the global market size of Disposable Hemoperfusion was estimated to be worth US$ 1320 million and is forecast to reach approximately US$ 3070 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 128
The global Disposable Hemoperfusion market size was US$ 1320 million in 2024 and is forecast to a readjusted size of US$ 3070 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 79
The global market for Disposable Hemoperfusion was estimated to be worth US$ 1320 million in 2024 and is forecast to a readjusted size of US$ 3070 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 108
The global market for Disposable Hemoperfusion was valued at US$ 1320 million in the year 2024 and is projected to reach a revised size of US$ 3070 million by 2031, growing at a CAGR of 13.0% during the forecast period.
Published: 2025-01-16
Pages: 79
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
Published: 2024-04-16
Pages: 152
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
Published: 2024-04-07
Pages: 105
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now